Literature DB >> 16330638

Advertisement woes.

George Vautour.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16330638      PMCID: PMC1316167          DOI: 10.1503/cmaj.1050240

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Controversies in the long-term management of analgesic therapy in patients with advanced cancer.

Authors:  R K Portenoy; N Coyle
Journal:  J Pain Symptom Manage       Date:  1990-10       Impact factor: 3.612

Review 2.  Hydromorphone: pharmacology and clinical applications in cancer patients.

Authors:  N Sarhill; D Walsh; K A Nelson
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

3.  Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.

Authors:  E Bruera; J Pereira; S Watanabe; M Belzile; N Kuehn; J Hanson
Journal:  Cancer       Date:  1996-08-15       Impact factor: 6.860

4.  Individual variability in the response to different opioids: report of five cases.

Authors:  Bradley S Galer; Nessa Coyle; Gavril W Pasternak; Russell K Portenoy
Journal:  Pain       Date:  1992-04       Impact factor: 6.961

5.  Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation.

Authors:  E Bruera; J J Franco; M Maltoni; S Watanabe; M Suarez-Almazor
Journal:  J Pain Symptom Manage       Date:  1995-05       Impact factor: 3.612

6.  Opioid rotation for toxicity reduction in terminal cancer patients.

Authors:  N D de Stoutz; E Bruera; M Suarez-Almazor
Journal:  J Pain Symptom Manage       Date:  1995-07       Impact factor: 3.612

7.  Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient.

Authors:  M Zheng; K M McErlane; M C Ong
Journal:  Xenobiotica       Date:  2002-05       Impact factor: 1.908

8.  Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride.

Authors:  J Katcher; D Walsh
Journal:  J Pain Symptom Manage       Date:  1999-01       Impact factor: 3.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.